OurMind lands €2.1M to help reduce healthcare workloads

Overview

OurMind, an Amsterdam-based healthtech startup, raised 2.1 million euros to expand an AI platform built to cut the paperwork load on doctors. The round was led by 4impact capital, the venture fund's first HealthTech investment, with backing from practicing general practitioners and medical specialists. The company's tools are already in use at more than 300 general practices and 14 hospitals across the Netherlands.

Key Takeaways

OurMind raised 2.1 million euros to grow an AI platform that reduces administrative work for doctors and other clinicians.
The funding round was led by 4impact capital and marks the Dutch fund's first investment in the healthtech sector.
A group of general practitioners and medical specialists also put money into the round, adding clinical credibility.
The flagship product, named Notes, turns spoken consultation conversations into structured medical documentation using AI.
OurMind's tools are already used at more than 300 general practices and 14 hospitals in the Netherlands.
The new capital will fund tools for consultation preparation, administrative support, and patient communication.

Stats & Key Facts

#2.1 million euros raised in the funding round.
#More than 300 general practices using OurMind's tools.
#14 hospitals across the Netherlands using the platform.
#4 founders started the company in 2024.
#2 to 3 hours per day spent by doctors preparing consultations, per the company.
#First HealthTech investment for lead investor 4impact capital.

OurMind Secures 2.1 Million Euros to Cut Clinician Paperwork

The funding targets a specific problem: doctors spending too much time on documentation instead of patients.

OurMind, a healthtech startup based in Amsterdam, raised 2.1 million euros to expand an AI platform built to reduce the administrative burden on medical staff. The company's goal is to free up clinician time so doctors and specialists handle more patient care as hospital demand keeps climbing.

The investment arrives as healthcare systems face longer waiting lists, heavier paperwork, and falling job satisfaction among staff. OurMind frames its technology as a way to ease that strain rather than replace clinical judgment.

4impact Capital Leads Its First Healthtech Deal

The round was led by a Dutch venture fund stepping into healthcare for the first time.

›4impact capital led the round and described it as the fund's first HealthTech investment.
›A group of practicing general practitioners and medical specialists also contributed capital.
›The deal is supported by Invest-NL and the European Union through the InvestEU Fund.
›Backing from working clinicians signals confidence from the people who would use the product daily.

Notes Turns Spoken Consultations Into Medical Records

The company's main product handles documentation during patient appointments.

OurMind's flagship product, called Notes, uses AI to convert spoken consultation conversations into structured medical documentation. It assists clinicians before, during, and after appointments, so the written record forms as the visit happens instead of afterward.

The tool has already reached scale inside the Dutch health system. More than 300 general practices and 14 hospitals use OurMind's tools, giving the startup a working base of users ahead of its expansion.

A Founding Team With Direct Clinical Experience

The startup pairs technical builders with someone who lived the workload problem.

›OurMind was founded in 2024 by Marco Ferraz, Paul Koning, Renan Sales Barros, and Fredrik Gustafsson.
›Co-founder Paul Koning is a former orthopaedic surgeon, giving the team firsthand knowledge of clinician paperwork.
›The mix of clinical and technical backgrounds shapes a product aimed at real consultation workflows.

The Documentation Burden Behind the Pitch

The product targets hours that doctors lose to preparation and admin.

The company points to a workload pattern familiar to many clinicians. Doctors spend two to three hours a day preparing consultations, often finishing the work at home in the evening.

OurMind argues that wider use of supportive technology is needed to ease this load and reduce burnout among medical staff. By automating routine documentation, the firm wants to return time to patient care rather than add another screen to manage.

Where the New Money Goes

The capital funds a broader platform beyond the original product.

›Development of tools for consultation preparation to help doctors get ready faster.
›Administrative support features that handle routine clerical tasks.
›Patient communication tools to streamline contact around appointments.
›Scaling the platform to meet rising demand from healthcare organisations facing longer waiting lists.

What This Means for Non-Technical Readers

Here is the plain-language takeaway for business observers watching healthtech.

AI documentation tools like Notes sit in a growing category often called ambient clinical documentation, where software listens to a visit and writes the record. The appeal is simple: less typing for the doctor and more attention for the patient.

OurMind's traction at 300-plus practices and 14 hospitals before this round suggests demand is real, not theoretical. The 2.1 million euros is an early-stage amount meant to broaden the product and reach more providers, not a large growth round, so the company is still proving it scales.

Frequently Asked Questions

How much did OurMind raise and who led the round?

OurMind raised 2.1 million euros. The round was led by 4impact capital, with additional money from a group of general practitioners and medical specialists.

What does OurMind's product actually do?

Its flagship product, Notes, uses AI to turn spoken consultation conversations into structured medical documentation. It supports clinicians before, during, and after patient appointments.

How widely is OurMind used already?

OurMind's tools are used by more than 300 general practices and 14 hospitals across the Netherlands.

Who founded OurMind and when?

OurMind was founded in 2024 by Marco Ferraz, Paul Koning, Renan Sales Barros, and Fredrik Gustafsson. Koning is a former orthopaedic surgeon.

What will the new funding be used for?

The money will fund new tools for consultation preparation, administrative support, and patient communication, and help scale the platform to meet rising demand from healthcare organisations.

OurMind's 2.1 million euro round gives the Amsterdam startup room to widen its AI documentation platform beyond the Notes product, with the stated aim of returning clinician time to patient care. Backing from practicing doctors and 4impact capital's first healthtech bet signals early confidence in the approach.